印度取消了17种癌症药物和罕见疾病治疗的进口关税,以降低成本。 India removes import duties on 17 cancer drugs and rare disease treatments to cut costs.

在2026-27年的联邦预算中,财政部长Nirmala Sitharaman宣布取消17种与癌症有关的药物的基本关税,扩大7种罕见疾病的免税进口准入,从而降低了救命的进口治疗费用。 In the 2026–27 Union Budget, Finance Minister Nirmala Sitharaman announced the removal of basic customs duty on 17 cancer-related drugs and expanded duty-free import access for seven rare diseases, reducing costs for life-saving imported treatments. 这一行动旨在减轻病人,特别是没有保险的病人的财政负担,改善获得诸如免疫疗法和有针对性的药物等先进疗法的机会。 The move aims to ease financial burdens on patients, particularly those without insurance, and improve access to advanced therapies like immunotherapies and targeted drugs. 虽然豁免药品的完整清单没有披露,但专家指出,减免可能降低5-10%的药品价格,每月可节省5 000至20 000欧元。 While the full list of exempted medicines was not disclosed, experts note the relief could lower drug prices by 5–10%, offering monthly savings of ₹5,000 to ₹20,000. 该政策是更广泛的海关改革的一部分,包括降低个人进口关税和简化受信任进口商的程序,尽管在解决总体癌症护理费用方面仍存在挑战。 The policy is part of broader customs reforms, including reduced duties on personal imports and streamlined processes for trusted importers, though challenges remain in addressing overall cancer care costs.